SUBSCRIBE
SUBSCRIBE

Georgiamune

NEWS
Map of NextGen Class of 2024/BioSpace
Business
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.
January 3, 2024
 · 
20 min read
 · 
BioSpace Editorial Staff
IN THE PRESS
Press Releases
Georgiamune Appoints Biopharma Veteran Mark Avagliano as Chief Business Officer to Drive Growth
November 19, 2024
 · 
3 min read
Press Releases
Georgiamune Announces First Patient Dosed in A First-In-Class Phase 1 Cancer Treatment Trial of GIM-531
July 30, 2024
 · 
3 min read
Business
UPDATE -- Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch
May 29, 2024
 · 
3 min read
AWARDS
  • NextGen Badge - Brighspot Rework_NextGen - Class of 2024.jpg
JOBS